SOHM Expanding Generic Drug Distribution Within Emerging Pharmaceutical Markets In Mexico and Latin America
Strategic Alliance In Mexico Expected to Accelerate Market Penetration and Revenue Growth BUENA PARK, CA, October 28, 2010 – SOHM, […]
Strategic Alliance In Mexico Expected to Accelerate Market Penetration and Revenue Growth BUENA PARK, CA, October 28, 2010 – SOHM, […]
BUENA PARK, CA, October 28, 2010 – SOHM, Inc. (Pink Sheets: SHMN), a generic pharmaceutical manufacturer that produces and markets
BUENA PARK, CA, October 27, 2010 – SOHM, Inc. (Pink Sheets: SHMN), a generic pharmaceutical manufacturer that produces and markets
49 First Line Products Including Topamax, Effexor XR, Lipitor, Plavix and Cymbalta To Lose Patent Protection Over The Next Five
Company Expected to Report Its Third Consecutive Quarter of Record Revenue As Sales of Generic Pharmaceutical Products Continue To Increase
BUENA PARK, CA, August 30, 2010 – SOHM, Inc. (Pink Sheets: SHMN), announced today its generic pharmaceutical marketing program received
SOHM Continues To Broaden International Sales Channels In Southeast Asia BUENA PARK, CA, August 27, 2010 – SOHM, Inc. (Pink
 Consumer Adoption of SOHM’s Private Label Generic Pharmaceutical Products Driving Unprecedented Corporate Revenue Growth BUENA PARK, CA, August 26,
Sales Continue To Grow in India’s $10 Billion Pharmaceutical Market With Increased Penetration Into Global Emerging Markets BUENA PARK, CA,
BUENA PARK, CA–(Marketwire – 07/13/10) – SOHM, Inc. (Pinksheets:SHMN – News), a generic pharmaceutical manufacturer that produces and markets generic